These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38570918)
1. Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer. Liu CQ; Shen CK; Du YX; Li ZM; Shi X; Wang Y; Wei WJ J Clin Endocrinol Metab; 2024 Oct; 109(11):2979-2985. PubMed ID: 38570918 [TBL] [Abstract][Full Text] [Related]
2. Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching. Tao Z; Deng X; Ding Z; Guo B; Fan Y Sci Rep; 2024 Jul; 14(1):17260. PubMed ID: 39068197 [TBL] [Abstract][Full Text] [Related]
3. Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study. Tao Z; Deng X; Ding Z; Guo B; Fan Y Front Endocrinol (Lausanne); 2024; 15():1433329. PubMed ID: 39268233 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and optimal candidates of primary tumor resection in major salivary gland carcinoma patients with distant metastases at initial presentation: A population-based study. Shi X; Dong F; Wei W; Song K; Huang N; Lu Z; Lei B; Yu P; Liu W; Wang Y; Sun G; Wang Y; Ji Q Oral Oncol; 2018 Mar; 78():87-93. PubMed ID: 29496064 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database. Meng K; Luo H; Chen H; Guo H; Xia W Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412 [TBL] [Abstract][Full Text] [Related]
7. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer. Roche AM; Fedewa SA; Chen AY JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481 [TBL] [Abstract][Full Text] [Related]
8. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma. Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144 [TBL] [Abstract][Full Text] [Related]
9. Role of primary tumor resection in patients with metastatic medullary thyroid cancer who have unresectable distant metastases. Zhuang SM; Xie LE; Pang F; Zhong QY; Sun XM; Wen WP; Liu TR Head Neck; 2021 Nov; 43(11):3386-3392. PubMed ID: 34423875 [TBL] [Abstract][Full Text] [Related]
10. The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma. Zhou TH; Zhao LQ; Zhang Y; Wu F; Lu KN; Mao LL; Jiang KC; Luo DC Front Endocrinol (Lausanne); 2021; 12():741289. PubMed ID: 34867784 [TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Leggett MD; Chen SL; Schneider PD; Martinez SR Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930 [TBL] [Abstract][Full Text] [Related]
13. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database. Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147 [TBL] [Abstract][Full Text] [Related]
15. Association between age and disease specific mortality in medullary thyroid cancer. Sahli ZT; Canner JK; Zeiger MA; Mathur A Am J Surg; 2021 Feb; 221(2):478-484. PubMed ID: 33010878 [TBL] [Abstract][Full Text] [Related]
16. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457 [TBL] [Abstract][Full Text] [Related]
17. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer. Machens A; Lorenz K; Dralle H Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475 [TBL] [Abstract][Full Text] [Related]
18. The Benefit of Primary Tumor Surgical Resection in Distant Metastatic Carcinomas of the Thyroid. Elsamna ST; Suri P; Mir GS; Roden DF; Paskhover B Laryngoscope; 2021 May; 131(5):1026-1034. PubMed ID: 32865854 [TBL] [Abstract][Full Text] [Related]
19. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis. Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396 [TBL] [Abstract][Full Text] [Related]
20. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis. Zheng M; Li Y; Li T; Zhang L; Zhou L Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]